Arbutus Biopharma Corp Payments of Stock Issuance Costs
Arbutus Biopharma Corp (ABUS) reported Payments of Stock Issuance Costs of $9.70 million for the 1-month period ending 2015-03-25, per its 10-Q filed 2015-05-06.
Discontinued › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2018-03-16
- 2015-03-25: Payments of Stock Issuance Costs 0 month $9.70M; Payments of Stock Issuance Costs $9.70M; Payments of Stock Issuance Costs 1 month $9.70M.
- 2014-03-26: Payments of Stock Issuance Costs $4.08M; Payments of Stock Issuance Costs 1 month $4.08M.
- 2013-11-02: Payments of Stock Issuance Costs $2.46M; Payments of Stock Issuance Costs 1 month $2.46M.
| Period end | Payments of Stock Issuance Costs 0 month | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs 1 month |
|---|---|---|---|
| 2015-03-25 | $9.70M 10-Q · filed 2015-11-05 | $9.70M 10-K · filed 2018-03-16 | $9.70M 10-Q · filed 2015-05-06 |
| 2014-03-26 | $4.08M 10-K · filed 2017-03-22 | $4.08M 10-Q · filed 2014-11-07 | |
| 2013-11-02 | $2.46M 10-K · filed 2016-03-09 | $2.46M 10-K · filed 2014-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Theravance Biopharma, Inc. (TBPH) | $0.885B | 16.40 |